Biotech

All Articles

BioMarin halts preclinical gene treatment for heart condition

.After BioMarin carried out a spring tidy of its own pipe in April, the company has actually made a ...

Eisai vegetations molecular glue SEED along with $1.5 B biobucks deal

.Huge Pharmas continue to be stuck to the tip of molecular glue degraders. The most recent company t...

Life scientific research credit report company reveals along with $600M

.A new worldwide life scientific research credit scores company, referred to Symbiotic Funding, has ...

BMS ditches TIGIT, ignoring $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing one more significant bet coming from the Caforio period, terminating ...

Nuvation standstills BET prevention after taking into consideration phase 1 data

.After taking a look at stage 1 information, Nuvation Biography has decided to halt work with its ow...

' Professional intuition' led FDA experts to back Zevra's uncommon condition med

.Zevra Rehabs' uncommon disease drug seems to be to become on the road to authorization this loss af...

Pfizer takes $230M reached after axing failed DMD genetics treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment breakdown has gone a $230 thous...

AC Immune views 'spots' prospective in Alzheimer's drug information

.After much more than twenty years of work with neurodegenerative health conditions, Swiss biotech a...

GSK falls ph. 2 HPV injection over absence of best-in-class potential

.GSK has actually ditched a stage 2 human papillomavirus (HPV) vaccine from its pipeline after deter...

OS Treatments refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.Operating system Therapies are going to detail on the NYSE American supply exchange this morning th...